| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/15/2004 | WO2003093422A3 Novel tissue factor targeted antibodies as anticoagulants |
| 07/15/2004 | WO2003089612A3 IMPROVED rAAV VECTORS |
| 07/15/2004 | WO2003089608A3 Drg11-responsive (dragon) gene family |
| 07/15/2004 | WO2003087195A3 Heterogeneous protein networks crosslinked with silicone-containing links, and methods for producing them |
| 07/15/2004 | WO2003070965A9 The eaat2 promoter and uses thereof |
| 07/15/2004 | WO2003063893B1 Fgfr agonists |
| 07/15/2004 | WO2003057831A3 Dtat fusion toxin |
| 07/15/2004 | WO2003051912A9 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
| 07/15/2004 | WO2003047506A3 Peptide agonists of prostate-specific antigen, and uses therefor |
| 07/15/2004 | WO2003044162A3 Genes encoding g-protein coupled receptors and methods of use therefor |
| 07/15/2004 | WO2003033645A3 Synthetic peptides and dna sequences for treatment of multiple sclerosis |
| 07/15/2004 | WO2002101074A3 Nucleic acid constructs useful for glucose regulated production of human insulin in somatic cell lines |
| 07/15/2004 | WO2002081636A3 Protein modification and maintenance molecules |
| 07/15/2004 | WO2002079389A3 Nucleic acid-associated proteins |
| 07/15/2004 | WO2002066613A3 Novel ecdysone receptor/invertebrate retinoid x receptor-based inducible gene expression system |
| 07/15/2004 | US20040139506 Auxin-repressed, dormancy-associated promoter and uses thereof |
| 07/15/2004 | US20040139505 Method for obtaining plants exhibiting enhanced resistance to water stress |
| 07/15/2004 | US20040139504 Suppression of specific classes of soybean seed protein genes |
| 07/15/2004 | US20040139503 Suppression of specific classes of soybean seed protein genes |
| 07/15/2004 | US20040139502 Suppression of specific classes of soybean seed protein genes |
| 07/15/2004 | US20040139500 Plastid division and related genes and proteins, and methods of use |
| 07/15/2004 | US20040139497 Comprises expression vector coding insecticidal polypeptide for use in generation and propagation of insect resistant plants; boiological pest control |
| 07/15/2004 | US20040139495 Control of bacterial infection by quenching quorum-sensing of plant pathogenic bacteria |
| 07/15/2004 | US20040139492 Genes encoding sulfate assimilation proteins |
| 07/15/2004 | US20040139488 Compositions and methods for enhancing disease resistance in fish |
| 07/15/2004 | US20040139485 cDNA encoding a gene BOG (B5T over-expressed gene) and its protein product |
| 07/15/2004 | US20040139484 Ras p27 animal models and uses thereof |
| 07/15/2004 | US20040138446 Biotin derivative with ether, amide or amine group for detection of drug interactions. |
| 07/15/2004 | US20040138443 Comprises nucleotide sequences coding interleukin receptor ligand for enhancing stimulation and regulation of host response to injury and infection |
| 07/15/2004 | US20040138442 Novel human transporter proteins and polynucleotides encoding the same |
| 07/15/2004 | US20040138441 Novel gene functionally related to dyslexia |
| 07/15/2004 | US20040138440 Aspergillus fumigatus cofilin |
| 07/15/2004 | US20040138431 Purification of NGF |
| 07/15/2004 | US20040138430 Novel polypeptide compose substance for promoting blood and blood vessel cell growth |
| 07/15/2004 | US20040138427 Chimeric monoclonal antibody for use as diagnostic and immunotherapeutic tool in treatment and prevention of infection, cancer, vascular, autoimmune, neurodegenerative and arthritic diseases; immunoassays |
| 07/15/2004 | US20040138423 Insecticidal compounds and methods for selection thereof |
| 07/15/2004 | US20040138422 Synthetic chemokines labeled at selected positions |
| 07/15/2004 | US20040138421 ACPL DNA and polypeptides |
| 07/15/2004 | US20040138420 Fluorescent proteins |
| 07/15/2004 | US20040138419 Inhibitor of cell proliferation and methods of use thereof |
| 07/15/2004 | US20040138418 Nucleotide sequences coding viral protein for use in identifying modulator and treatment of lymphoproliferative and cell proliferative disease; genetic vaccines |
| 07/15/2004 | US20040138417 Chimeric heteromultimer adhesins |
| 07/15/2004 | US20040138416 Comprises membrane protein for use in diagnosis prevention and treatment of cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune, inflammatory, metabolic and viral disorders |
| 07/15/2004 | US20040138415 Helicobacter proteins, nucleic acids and uses thereof |
| 07/15/2004 | US20040138414 Secreted proteins |
| 07/15/2004 | US20040138413 Compositions and methods for immunoaffinity purification |
| 07/15/2004 | US20040138412 ligating a first component comprising a carboxyl thioester, an alpha -carboxyl thioester with a second component comprising an acid stable N-substituted, and preferably, N alpha -substituted, 2 or 3 carbon chain amino alkyl or aryl thiol |
| 07/15/2004 | US20040138244 Contraceptices; hormone sensitivity diseases; antidepressants; sexual disorders ; osteoporosis; alopecia |
| 07/15/2004 | US20040138166 Viricides; prevent reproduction, infections |
| 07/15/2004 | US20040138162 Method of resisting osteoclast formation |
| 07/15/2004 | US20040138158 Cea-expression inhibiting ribozymes and methods for the treatment of cancer based thereon |
| 07/15/2004 | US20040138155 for treatment of central and/or peripheral nervous system injury; neurons; fibroblast growth factor receptors; biocompatability |
| 07/15/2004 | US20040138137 Alloferons - immunomodulatory peptides |
| 07/15/2004 | US20040138136 Cyclic peptide compositions and methods for treatment of sexual dysfunction |
| 07/15/2004 | US20040138135 immunogens; immunotherapy; antigen presenting cells |
| 07/15/2004 | US20040138134 Method and composition for treatment of skeletal dysplasias |
| 07/15/2004 | US20040138132 Membrane translocating peptide drug delivery system |
| 07/15/2004 | US20040138131 inhibiting virus attachment to hepatocytes via exposing to recombinant urine derived protein |
| 07/15/2004 | US20040138130 Active modified hedgehog proteins |
| 07/15/2004 | US20040138129 for increasing production of reticulocytes and red blood cells; for treatment of anemia/renal failure/cancer |
| 07/15/2004 | US20040138126 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR) |
| 07/15/2004 | US20040138124 immunostimulants used for prophylaxis or prevention diseases related to enzymatic deficiency, to stimulate in vivo hydrolysis of xenobiotics, drugs and toxins, or as antiallergens; metabolic and genetic disorders |
| 07/15/2004 | US20040138123 Fibroblast growth factor peptide fragments having deletions in the amino acid sequences, conjugates with ricin, diphtheria or saporin, and carrier mixtures, used as wound heling agents or antiproliferative agents |
| 07/15/2004 | US20040138122 Methods for treating viral infection using IL-28 and IL-29 |
| 07/15/2004 | US20040138120 Hepatocyte growth factor variants |
| 07/15/2004 | US20040138118 polypeptide comprises amino acid sequences having point mutations of cleavage sites for metalloenzymes, used for prophylaxis of metabolic and muscular disorders; bone morphogenetic protein/tolloid or tolloid-like protein complexes |
| 07/15/2004 | US20040138115 DNA sequence comprising endorphin codes for proopiomelanocortin genes (POMC), deleted of the coding regions for adrenocorticotropic hormone (ACTH) and beta-melanocyte stimulating hormone ( beta -MSH); anlagesics; gene therapy |
| 07/15/2004 | US20040138114 nucleotide sequences codes for polypeptide used for diagnosis and prophylaxis of autoimmune diseases |
| 07/15/2004 | US20040138113 Administering heterodimeric polypeptides and optionally as mixtures with steroids, to mammals, as antiinflammatory agents; side effect reduction |
| 07/15/2004 | US20040138112 Vaccines |
| 07/15/2004 | US20040138111 Composition and method to alter lean body mass and bone properties in a subject |
| 07/15/2004 | US20040138110 administering plasminogen activator inhibitors comprising cyclic peptides as antitumor agents; tissue-targeted therapy |
| 07/15/2004 | US20040138106 Glycoprotein synthesis |
| 07/15/2004 | US20040138101 Prophylaxis of bone disorders comprising administering insulin and derivatives, and optionally in combination with peptide growth factors, metabolic antagonist, osteoprotegerins, synovial or antiinflammatory agents, in sustained release form |
| 07/15/2004 | US20040138100 biochemical conjugates comprising protein carriers such as albumin complexed with peptides that stimulate the biosynthesis or gene expression of insulin, used as sustained release agents for prophylaxis of metabolic disorders; bioavailability |
| 07/15/2004 | US20040138096 Immunoregulator |
| 07/15/2004 | US20040137642 Major histocompatibility complex fusion protein for use as diagnostic tool in monitoring antigen specific cellular immune response |
| 07/15/2004 | US20040137622 Modular transfection systems |
| 07/15/2004 | US20040137621 Mesenchymal stem cells as a vehicle for ion channel transfer in syncytial structures |
| 07/15/2004 | US20040137620 Compositions corresponding to a calcium transporter and methods of making and using same |
| 07/15/2004 | US20040137611 Cypridina luciferase fusion for use as diagnostic tool in monitoring synaptic response |
| 07/15/2004 | US20040137601 Amino acid sequences for therapeutic and prophylactic use against diseases due to clostridium difficile toxins |
| 07/15/2004 | US20040137597 Substrates of N-end rule ubiquitylation and methods for measuring the ubiquitylation of these substrates |
| 07/15/2004 | US20040137595 Mfq-111, a novel human gtpase like protein |
| 07/15/2004 | US20040137589 Human myosin-like polypeptide expressed predominantly in heart and muscle |
| 07/15/2004 | US20040137588 Using affinity chromatograpy to isolate and separate vasoactive permeability factor from fluids; disease diagnostics |
| 07/15/2004 | US20040137581 Interferon variants with improved properties |
| 07/15/2004 | US20040137580 for treating or preventing hyperacute rejection; solid phase synthesis; genetic engineering |
| 07/15/2004 | US20040137579 Protein complexes having factor VIII:C activity and production thereof |
| 07/15/2004 | US20040137578 Chemokine TECK polypeptides |
| 07/15/2004 | US20040137577 B7-H2 molecules, novel members of the B7 family and uses thereof |
| 07/15/2004 | US20040137575 Human 2-19 protein homologue, z219c |
| 07/15/2004 | US20040137574 for drug screening G-protein coupled receptors (GPCRs) inhibitors |
| 07/15/2004 | US20040137573 for drug screening treatments for pain, neuropathy, rheumatoid/osteo arthritis, stroke, inflammation, asthma, allergy, urogenital disorders, incontinence, hypertension, hypotension, perivasular disease; animal models; kits |
| 07/15/2004 | US20040137569 Notch receptor ligands and uses thereof |
| 07/15/2004 | US20040137568 for treatment of infection by injection of dose between 1x103 and 1x107 bacteria per kg |
| 07/15/2004 | US20040137566 Identification of novel ms4a gene family members expressed by hematopoietic cells |
| 07/15/2004 | US20040137564 for diagnosing, treating, or preventing cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory, and metabolic disorders, and viral infections;solid phase synthesis |
| 07/15/2004 | US20040137563 Endogenous and non-endogenous versions of human G protein-coupled receptors |
| 07/15/2004 | US20040137562 Genetically-engineered mhc molecules |